BioSTL

What BioSTL does

BioSTL is a St. Louis-based 501(c)(3) nonprofit (EIN: 45-2137574) founded in 2001 that functions as a regional bioscience innovation ecosystem builder rather than a product technology company. The organization convenes researchers, entrepreneurs, healthcare systems, ag corporations, farmers, and investors into a single coordinated cluster centered on St. Louis' Cortex Innovation District and 39 North / Helix Center, leveraging 25 years of accumulated coalition capital. Its core operating subsidiaries are BioGenerator (the startup investment and company-building arm, with over $50M deployed across 140+ ventures whose portfolio has attracted $2.8B-$3B from 200+ global investors at greater than 60X leverage) and BioSTL Global (the international partnership and soft-landing arm). BioSTL does not develop proprietary technology products; its "platform" is a coordinated portfolio of programs covering the full startup lifecycle, including BioGenerator Labs (shared lab facilities that have hosted 200+ companies), Startup Connect (invite-only investor conference), the Healthcare Buyer Platform (curated BD meetings representing $550B+ in purchasing power), Innovators Hour (monthly founder storytelling), BIOTECH for MO (workforce training targeting 350 individuals), the Venture Fellows program, NEURO360, EAGIC (farmer trial network), Global AgXelerate (India-US agtech gateway), the Global Health Innovation Summit, the Global AgriFood Innovation Summit, the inaugural Breakthrough Gala, and Cultivar STL (Latin American startup access fund).

BioSTL's revenue model is a mix of philanthropic giving (individual, corporate, and foundation donations via cash, DAFs, stock, QCDs, and bequests), event sponsorships (multi-tier packages for the annual Breakthrough Gala and summits), government and foundation grants (e.g., $2M from Missouri DED for BIOTECH for MO; historical $1.5M-$30M grants from EDA, Bayer, and JP Morgan Chase), and BioGenerator's equity-linked investment activity across the human health and agriculture portfolio. Programs and services are offered to ecosystem participants at no direct cost. Customers and partners span large enterprise health systems (BJC HealthCare, SSM Health, Ascension, Mercy, Evernorth/Cigna, Centene), global agrifood majors (AB InBev, ADM, Bayer, Bunge, Nestle Purina, Post, Burger King), research institutions (Washington University, Donald Danforth Plant Science Center), national commodity and farm bureau organizations, and 140+ portfolio startups spanning cell therapy, diagnostics, ag biotech, geospatial, and applied AI.

Geographically, BioSTL operates as a St. Louis-headquartered organization with formal international reach into the UK (via NHS Health Innovation Networks and Yorkshire & Humber), India (via AgVaya), Latin America (via Cultivar STL, Embrapa, ARISE), and Rwanda (emerging economic partnership commentary), funded by a UK government grant for ARISE. Go-to-market is community-led and event-driven: a calendar of summits, galas, investor conferences, and curated BD meetings serves as the primary demand-generation and partnership-formation mechanism, anchored by content marketing, newsletters (The Sequence), a YouTube channel, LinkedIn presence, and a podcast.

Name

BioSTL

Legal name

BioSTL

Website

https://biostl.org

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

BioSTL is a St. Louis-based nonprofit founded in 2001 that builds the regional bioscience innovation ecosystem through BioGenerator's early-stage capital and lab facilities, BioSTL Global's international soft-landing programs, summits, and workforce training serving startups, healthcare systems, ag corporations, and research institutions.

Ownership category

akta.pro rank

Product category

Bioscience Innovation Ecosystem Development

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000), Agricultural Services (700)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

akta.pro secondary industry

Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)

Keywords

• Bioscience innovation ecosystem
• Startup investment programs
• Healthcare innovation summits
• Agrifood convening events
• Workforce development training

Headquarters

HQ city

St Louis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others, Infrastructure

Revenue model

1. Donations and Philanthropic Support: As a 501(c)(3) nonprofit organization (EIN: 45-2137574), BioSTL relies on charitable donations from individuals, corporations, and foundations. Contributions are tax-deductible to the extent allowed by law. The organization accepts cash/check donations, gifts through Donor-Advised Funds (DAF), gifts of stock, Qualified Charitable Distributions from IRAs, and legacy/bequest gifts.
2. Gala and Event Sponsorships: The annual Breakthrough Gala and other events generate sponsorship revenue from corporate sponsors at various tiers (Premier, Diamond, Gold, Silver, Bronze). Sponsors receive recognition and benefits based on their contribution level.
3. BioGenerator Investment Returns: BioGenerator, BioSTL's startup investment arm, generates returns through equity investments in early-stage bioscience companies. BioGenerator has invested over $50 million in startups and portfolio companies have raised $3 billion from investors.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

BioSTL is a 501(c)(3) nonprofit that builds and convenes the St. Louis bioscience innovation ecosystem. Through its investment arm BioGenerator, it provides catalytic early-stage capital, lab space, and company-building resources to life sciences startups in human health and agriculture. It also runs international soft-landing programs (BioSTL Global, Global AgXelerate), workforce training (BIOTECH for MO, Venture Fellows), and convenes flagship annual events (Global Health Innovation Summit, Global AgriFood Innovation Summit, Breakthrough Gala, Startup Connect).

Product overview

BioSTL is a nonprofit bioscience innovation organization that functions as an ecosystem builder rather than a product company in the traditional sense. Its offering is a coordinated portfolio of programs and services that support the full lifecycle of bioscience startup creation and growth. The core investment and company-building arm is BioGenerator Ventures (including BioGenerator Labs for lab facilities), which is supplemented by a rich calendar of convening programs including Innovators Hour (monthly founder storytelling sessions), Startup Connect (annual invite-only investment conference), Breakthrough Gala (annual fundraising event), Global AgriFood Innovation Summit (annual agriculture innovation conference), and Global Health Innovation Summit (annual healthcare innovation conference). Supporting programs include the BIOTECH for MO statewide workforce training initiative, the Early Adopter Grower Innovation Community (EAGIC) connecting agtech startups with trial farms, Global AgXelerate (international agtech soft-landing program), Venture Fellows Program (training scientists in entrepreneurship), and NEURO360 (neuroscience hub initiative). These programs collectively cover startup acceleration, capital investment, talent development, workforce training, international market access, and convening — forming a comprehensive innovation ecosystem.

Differentiator

Problem solved

Functional benefit

Products and services

• BioGenerator Ventures

Quantifiable outcome

• Over $50M invested in 140+ early-stage startups, with portfolio companies raising $3B from 200+ global investors (60X leverage)
• +5 more outcomes

Named customers16 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

17 partnerships are on record, tiered core and minor.

• NHS Health Innovation Networks (UK)coreStrategic or Co-development Partner · 15 June 2026BioSTL Global signed an agreement with the UK's National Health Service Health Innovation Networks to establish St. Louis as a gateway for British digital health startups entering the U.S. market. The partnership connects UK innovators with St. Louis' $500 billion healthcare ecosystem for pilots, licensing, and commercial scaling of AI and digital health technology.
• Health Innovation Yorkshire & HumbercoreStrategic or Co-development Partner · 15 June 2026Signed a collaboration agreement to support health and life sciences businesses in the Yorkshire and Humber region. The partnership provides access to BioSTL's network of investors, healthcare providers, research institutions, and industry partners, including joint trade missions, mentorship, and knowledge-sharing activities aimed at helping innovators expand internationally.
• Agri-TechEcoreStrategic or Co-development Partner · 29 January 2026Partner in the ARISE (AgriTech for Resilience, Innovation & Sustainable Ecosystems) initiative, a trilateral platform connecting science, technology, and investment ecosystems across the UK, US, and Latin America through capability mapping, startup evaluation, and knowledge exchange.
• Embrapa (Brazil)coreStrategic or Co-development Partner · 29 January 2026Partner in the ARISE initiative, connecting Brazilian agricultural research capabilities with UK and US innovation ecosystems for food security and sustainable agriculture collaboration.
• Agri TIERR AcoreStrategic or Co-development Partner · 29 January 2026Partner in the ARISE initiative focused on strengthening international cooperation around food security and sustainable agriculture through research, commercial, and farmer partnerships.
• World Trade Center St. LouisminorStrategic or Co-development Partner · 29 January 2026Partner in ARISE initiative, with relationship-building efforts dating back to 2017 supporting international trade and delegation visits including the ARISE cohort visiting St. Louis in February 2026.
• Donald Danforth Plant Science CentercoreStrategic or Co-development Partner · 10 November 2025The Donald Danforth Plant Science Center administers the Core Facilities Access Fund, an initiative of Cultivar STL designed to help Latin American startups access US markets via world-class plant science facilities. Breakthrough Energy Discovery supports the fund.
• AgVaya LLP (India)coreStrategic or Co-development Partner · 15 October 2025Launched Global AgXelerate, a new international collaboration platform designed to connect agriculture innovators, startups, and industry leaders with opportunities to establish their US base in St. Louis. The partnership was officially launched at the seminar 'Innovations for Regenerative Agriculture – Indian and Global Experiences' in New Delhi.
• The Yield Lab InstitutecoreStrategic or Co-development PartnerPartner in the Cultivar STL initiative and Core Facilities Access Fund selection committee. A agrifood think tank and ecosystem connector headquartered in St. Louis, non-profit affiliate of The Yield Lab Group.
• ReACH Coalition Members (AB InBev, ADM, Bayer, Bunge, Burger King, Donald Danforth Plant Science Center, Growmark, ICL, Illinois Farm Bureau, Missouri Farm Bureau, National Corn Growers Association, Nestlé Purina, Post, Taylor Geospatial Institute, United Soybean Board, Gates Ag One, Washington University, 39 North)coreStrategic or Co-development PartnerThe ReACH (Regenerative Agrifood Coalition in the Heartland) is a collaboration of regional food and agriculture corporations, farmers, national commodity organizations, research institutions and farm bureaus representing the entire ag value chain. Coalition members leverage global innovation to build a more sustainable agrifood system.
• NEURO360 Partnership Network (50+ organizations)coreStrategic or Co-development PartnerNEURO360, led by WashU and BioSTL, has assembled a neurotechnology network with over 50 organizations contributing more than $60 million in resources. Despite not being selected for NSF Engines grant, the initiative continues to foster a robust neuroscience innovation ecosystem in St. Louis.
• Jackie Joyner-Kersee FoundationminorStrategic or Co-development PartnerPartnership in opening an innovation center focused on growing St. Louis' bioscience talent pipeline. Represents BioSTL's workforce development and talent pipeline building efforts in the community.
• BJC HealthCarecoreStrategic or Co-development PartnerKey healthcare system partner in BioSTL's Global Health Innovation Summit and Healthcare AI Collaborative. Represented at the $550B+ Healthcare Buyer Platform. BJC/WashU Innovation Center is a major healthcare innovation hub in St. Louis.
• SSM HealthcoreStrategic or Co-development PartnerMajor health system partner in BioSTL's healthcare innovation ecosystem. $11.4B revenue from 23 hospitals across 4 states. Key participant in Global Health Innovation Summit.
• AscensioncoreStrategic or Co-development PartnerLargest non-profit hospital system in USA with $27.2B revenue from 151 hospitals across 22 states. Key buyer participant in BioSTL's healthcare innovation programs.
• Evernorth / CignacoreStrategic or Co-development PartnerLeading Health Service Company combining payer and PBM capabilities with $212B in revenue. Participant in BioSTL's Healthcare Buyer Platform connecting innovators with major healthcare purchasers.
• CentenecoreStrategic or Co-development PartnerLargest Medicaid & Exchange Managed Care Company in USA with $154B in revenue across 50 states. Key payer partner in BioSTL's healthcare innovation initiatives.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Biocom: California's largest life-science industry association, advocating for and convening biotech companies, investors, and research institutions across San Diego, San Francisco, Los Angeles, and Washington DC. Directly comparable to BioSTL as a regional bioscience ecosystem builder with policy advocacy, capital access, and event programs.
• MassBio: Massachusetts Biotechnology Council is the leading bioscience industry association for the Boston/Cambridge cluster, providing networking events, policy advocacy, and ecosystem services to member biotech companies. Most direct peer to BioSTL in terms of mission (regional bioscience convening/advocacy) and stakeholder mix.
• BioNJ: New Jersey's life sciences trade association serving the state's bioscience industry through advocacy, networking, and educational programming. Direct peer to BioSTL as a regional bioscience industry association with convening and policy functions.
• BioEnterprise / JumpStart Health: Formerly BioEnterprise, JumpStart Health is a Cleveland-based bioscience innovation organization that funds, advises, and accelerates health IT, biotech, and medical device companies in Northeast Ohio. Direct peer to BioSTL/BioGenerator as a regional health-innovation investor and accelerator with a similar Midwest geographic profile.
• Innovation Works: Pittsburgh-based early-stage investor and innovation hub that funds and supports technology and life sciences startups across Southwestern Pennsylvania. Comparable to BioGenerator's role within BioSTL — providing seed/Series A capital and operational support to early-stage science-based startups in a Rust Belt region.
• Activate (formerly Cyclotron Road): Berkeley-based fellowship supporting entrepreneurial scientists translating research into hard-tech and biotech companies. Comparable to BioSTL's Venture Fellows program and BioGenerator's catalytic-capital model for science-based founders.
• Mind the Bridge: San Francisco-based global innovation advisory that runs international soft-landing programs connecting startups from Europe, Israel, and Asia to Silicon Valley. Highly comparable to BioSTL Global's NHS, AgVaya, and ARISE international soft-landing partnerships.

Broad incumbents

• ARCH Venture Partners: One of the largest early-stage biotech venture investors, with a portfolio spanning therapeutics, diagnostics, and biotech platforms. Comparable to BioGenerator's investment function at a vastly larger scale and broader geographic reach.

Others

• Cortex Innovation Community: St. Louis-based innovation district where BioGenerator Labs is headquartered. Adjacent ecosystem partner and physical host of BioSTL's lab infrastructure; not a direct competitor but a co-located community serving similar startups.
• 39 North / BRDG Park: St. Louis agtech innovation district hosting the Helix Center where BioGenerator Labs operates. Adjacent ecosystem player serving the same agtech startups as BioSTL's ag innovation programs but focused on real estate rather than convening/investing.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@biostl
• LinkedInlinkedin.com/company/biostl
• Xx.com/BioSTL
• Facebookfacebook.com/BioSTL

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries2 records

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioSTL